BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8392486)

  • 1. New octreotide derivatives for in vivo targeting of somatostatin receptor-positive tumors for single photon emission computed tomography (SPECT) and positron emission tomography (PET).
    Mäcke HR; Smith-Jones P; Maina T; Stolz B; Albert R; Bruns C; Reist H
    Horm Metab Res Suppl; 1993; 27():12-7. PubMed ID: 8392486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
    Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
    Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies.
    Smith-Jones PM; Stolz B; Bruns C; Albert R; Reist HW; Fridrich R; Mäcke HR
    J Nucl Med; 1994 Feb; 35(2):317-25. PubMed ID: 8295005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors.
    Eisenwiener KP; Prata MI; Buschmann I; Zhang HW; Santos AC; Wenger S; Reubi JC; Mäcke HR
    Bioconjug Chem; 2002; 13(3):530-41. PubMed ID: 12009943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
    Ugur O; Kothari PJ; Finn RD; Zanzonico P; Ruan S; Guenther I; Maecke HR; Larson SM
    Nucl Med Biol; 2002 Feb; 29(2):147-57. PubMed ID: 11823119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-pharmacokinetics of 18F-octreotide: a comparison with 67Ga-DFO- and 86Y-DTPA-octreotide.
    Wester HJ; Brockmann J; Rösch F; Wutz W; Herzog H; Smith-Jones P; Stolz B; Bruns C; Stöcklin G
    Nucl Med Biol; 1997 May; 24(4):275-86. PubMed ID: 9257325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat.
    Bruns C; Stolz B; Albert R; Marbach P; Pless J
    Horm Metab Res Suppl; 1993; 27():5-11. PubMed ID: 8392488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
    Kowalski J; Henze M; Schuhmacher J; Mäcke HR; Hofmann M; Haberkorn U
    Mol Imaging Biol; 2003; 5(1):42-8. PubMed ID: 14499161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
    De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
    J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of copper-64-octreotide conjugates.
    Anderson CJ; Pajeau TS; Edwards WB; Sherman EL; Rogers BE; Welch MJ
    J Nucl Med; 1995 Dec; 36(12):2315-25. PubMed ID: 8523125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results.
    Maina T; Nock B; Nikolopoulou A; Sotiriou P; Loudos G; Maintas D; Cordopatis P; Chiotellis E
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):742-53. PubMed ID: 12029547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-receptor imaging in the localization of endocrine tumors.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
    van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
    World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
    Vallabhajosula S; Moyer BR; Lister-James J; McBride BJ; Lipszyc H; Lee H; Bastidas D; Dean RT
    J Nucl Med; 1996 Jun; 37(6):1016-22. PubMed ID: 8683294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
    J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc targeting of Sst2-expressing tumors by tetraamineoctreotide: first results in CA20948 cells and rat models.
    Nikolopoulou A; Nock BA; Maina T
    Anticancer Res; 2006; 26(1A):363-6. PubMed ID: 16475719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
    Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
    Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.
    Schottelius M; Wester HJ; Reubi JC; Senekowitsch-Schmidtke R; Schwaiger M
    Bioconjug Chem; 2002; 13(5):1021-30. PubMed ID: 12236784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.